Multiple Sclerosis Patients' Benefit-Risk Preferences: Serious Adverse Event Risk versus Treatment Efficacy
Johnson, F., Van Houtven, G., Ozdemir, S., Hass, S., White, J., Francis, G., Miller, D., & Phillips, T. (2009). Multiple Sclerosis Patients' Benefit-Risk Preferences: Serious Adverse Event Risk versus Treatment Efficacy. Journal of Neurology, 256, 554 - 562.
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Epigenetic biomarkers for smoking cessation
A pilot PT scheme for external assessment of laboratory performance in testing synthetic opioid compounds in urine, plasma, and whole blood